Northwire Canada EditionFriday, July 17, 2026
Sign inSubscribe
Northwire
⌕
LUN 33.59 −2.5% NTR 94.27 −1.8% LALI 0.055 −8.3% SCD 0.170 +0.0% HWY 0.370 +0.0% FCI 0.385 +1.3% GGAU 0.180 −5.3% KIRO 0.650 +1.6% LBNK 0.430 +0.0% BARU 0.040 +0.0% VCU 1.09 −4.4% NOBL 0.095 −5.0% SHL 0.355 +0.0% MTS 0.130 +0.0% FYL 0.090 +0.0% NUAG 5.55 +1.8% LUN 33.59 −2.5% NTR 94.27 −1.8% LALI 0.055 −8.3% SCD 0.170 +0.0% HWY 0.370 +0.0% FCI 0.385 +1.3% GGAU 0.180 −5.3% KIRO 0.650 +1.6% LBNK 0.430 +0.0% BARU 0.040 +0.0% VCU 1.09 −4.4% NOBL 0.095 −5.0% SHL 0.355 +0.0% MTS 0.130 +0.0% FYL 0.090 +0.0% NUAG 5.55 +1.8%

Healthcare

Page 98
  1. Nov 20, 2025 · 13:30 · BNXT

    Bionxt Solutions receives Eurasian patent grant

    Bionxt Solutions receives Eurasian patent grant

    01
  2. Nov 20, 2025 · 09:01 · HEM

    Dr. William R. Shankle to Advance ACP-01 as a Treatment for Vascular Dementia

    Dr. William R. Shankle to Advance ACP-01 as a Treatment for Vascular Dementia

    02
  3. Nov 20, 2025 · 08:00 · NURS

    Hydreight Technologies Ranked #77 Fastest-Growing Company in North America on the 2025 Deloitte Technology Fast 500(TM)

    Hydreight Technologies Ranked #77 Fastest-Growing Company in North America on the 2025 Deloitte Technology Fast 500(TM)

    03
  4. Nov 20, 2025 · 07:31 · MDP

    Medexus Announces Normal Course Issuer Bid, or NCIB, for Its Common Shares

    Medexus Announces Normal Course Issuer Bid, or NCIB, for Its Common Shares

    04
  5. Nov 20, 2025 · 07:30 · BCT

    BriaCell and Receptor.AI to Collaborate on AI Driven Small Molecule Cancer Therapeutics

    BriaCell and Receptor.AI to Collaborate on AI Driven Small Molecule Cancer Therapeutics

    05
  6. Nov 20, 2025 · 07:01 · WELL

    WELL Health Reports Strong Organic Growth, Major Advances in Clinic Digitization, and Rapid Progress on New Primary Care Patient Openings

    WELL Health Reports Strong Organic Growth, Major Advances in Clinic Digitization, and Rapid Progress on New Primary Care Patient Openings

    06
  7. Nov 20, 2025 · 07:01 · PREV

    PreveCeutical Provides Update on Plan of Arrangement with BioGene Therapeutics Inc.

    PreveCeutical Provides Update on Plan of Arrangement with BioGene Therapeutics Inc.

    07
  8. Nov 20, 2025 · 07:00 · LSL

    LSL PHARMA GROUP REPORTS FOURTH CONSECUTIVE RECORD QUARTERLY REVENUES AND Q3 2025 FINANCIAL RESULTS

    LSL PHARMA GROUP REPORTS FOURTH CONSECUTIVE RECORD QUARTERLY REVENUES AND Q3 2025 FINANCIAL RESULTS

    08
  9. Nov 20, 2025 · 03:05 · BNXT

    BioNxt Secures Final Patent Grant from the Eurasian Patent Organization for Sublingual Cladribine Platform

    BioNxt Secures Final Patent Grant from the Eurasian Patent Organization for Sublingual Cladribine Platform

    09
  10. Nov 19, 2025 · 20:16 · SURE

    Surenano Science signs LOI to acquire GlucaPharm

    Surenano Science signs LOI to acquire GlucaPharm

    10
  11. Nov 19, 2025 · 17:38 · AIDR

    Rocket Doctor firms up deal to acquire Alea Health

    Rocket Doctor firms up deal to acquire Alea Health

    11
  12. Nov 19, 2025 · 17:18 · EXE

    Extendicare to Expand its Home Health Care Business by Acquiring CBI Home Health for $570 Million in Cash Consideration

    Extendicare to Expand its Home Health Care Business by Acquiring CBI Home Health for $570 Million in Cash Consideration

    12
  13. Nov 19, 2025 · 17:00 · MPH

    Medicure Reports Financial Results for Quarter Ended September 30, 2025

    Medicure Reports Financial Results for Quarter Ended September 30, 2025

    13
  14. Nov 19, 2025 · 16:31 · SURE

    SureNano Announces Non-Binding Letter of Intent to Negotiate Proposed Transaction of GlucaPharm Inc. for GLP-1 Drug Development

    SureNano Announces Non-Binding Letter of Intent to Negotiate Proposed Transaction of GlucaPharm Inc. for GLP-1 Drug Development

    14
← Newer Older →